Adalimumab (Humira) and biosimilars: medicine used for ...
NHS medicines information on adalimumab – what it's used for, side effects, dosage and who can take it.
Humira (adalimumab): Side effects, cost, uses, and more
It's not known exactly what leads to HS, but an overactive immune system is believed to be one possible cause. Humira treats HS by blocking a protein called ...
Adalimumab - Wikipedia
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid ...
HUMIRA® (adalimumab) | For Healthcare Professionals
Ulcerative Colitis: HUMIRA is indicated for the treatment of moderately to severely active ulcerative colitis in adults and pediatric patients 5 years of age ...
Humira (adalimumab) label
See full prescribing information for. HUMIRA. HUM. IRA (adalimumab) Injection, Solution for Subcutaneous use. Initial U.S. Approval: 2002. WARNINGS:.
Adalimumab (Humira®) Drug Information Sheet : Johns Hopkins
Adalimumab can lower the body's ability to fight infection. Be sure to contact your physician if you have any signs of infection, such as fever, fatigue, cough, ...
HUMIRA® (adalimumab) - A Biologic Medication
HUMIRA is a prescription medicine used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, ...
Humira | European Medicines Agency
Name of medicine. Humira ; Active substance. adalimumab ; International non-proprietary name (INN) or common name. adalimumab ; Therapeutic area (MeSH).
Safety analyses of adalimumab (HUMIRA) in global clinical trials ...
Analyses of these data demonstrate that long term adalimumab treatment is generally safe and well tolerated in patients with RA.
HUMIRA | RxAbbVie
kg) or 40 mg adalimumab (if ≥ 30 kg) every other week in combination with a dose of rimary endpoint was 'time to treatment failure'. The criteria ...